How much funding has Renovis raised?

Renovis has raised $45.0M in total funding, most recently a Venture Round.

Who are Renovis's investors?

Renovis's investors include Alta Partners, Venrock, Flagship Pioneering, Skyline Global Partners.

Where is Renovis headquartered?

Renovis is headquartered in South San Francisco, California, United States.

What industry is Renovis in?

Renovis operates in Biotech, Healthcare.

Renovis

South San Francisco, United States · Founded 2000 · $45.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2000
Business Model: B2B

Total Funding: $45.0M
Last Round: $45.0M Venture RoundJan 2007
Rounds: 2

About

Renovis, Inc. was a biopharmaceutical company founded in 2000 by UC Berkeley and UCSF faculty—including neuroscientist Corey Goodman—focused on discovering and developing small molecule drugs to treat neurological diseases and disorders. The company applied molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism, and informatics to identify drug candidates targeting purinergic receptors (P2X3 and P2X7) for the potential treatment of pain and inflammatory conditions. Renovis was acquired by Evotec AG in 2008 in a $152 million stock deal.

Summary

Renovis is a Biotech company based in South San Francisco, United States, founded in 2000. It has raised $45.0M in total across 2 rounds, most recently a $45.0M Venture Round round in Jan 2007. Investors include Alta Partners, Venrock and Flagship Pioneering.